|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||||||||||||||
|
|||||||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s4F84ED8A-5A1D-11EF-B837-C0B384CE164B&I=39IZM&T=&OP=Display&O=html&O1=15082072&O2=954925517559&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DEvaluation%2520of%2520the%2520comparative%2520efficacy%2520and%2520tolerability%2520of%2520rofecoxib%2520and%2520naproxen%2520in%2520children%2520and%2520adolescents%2520with%2520juvenile%2520rheumatoid%2520arthritis%253A%2520a%252012-week%2520randomized%2520controlled%2520clinical%2520trial%2520with%2520a%252052-week%2520open-label%2520extension%26rft.au%3DAdelsberg%252C%2520Janet%2520Van%26rft.au%3DKiss%252C%2520Maria%2520H%2520B%26rft.au%3DLovell%252C%2520Daniel%2520J%26rft.au%3DReiff%252C%2520Andreas%26rft.date%3D2006-05-01%26rft.eissn%3D1499-2752%26rft.externalDocID%3D16583464%26rft.genre%3Darticle%26rft.issn%3D0315-162X%26rft.issue%3D5%26rft.jtitle%3DJournal%2520of%2520rheumatology%26rft.spage%3D985%26rft.volume%3D33%26rft_id%3Dinfo%253Apmid%252F16583464%26rft_id%3Dinfo%253Apmid%252F16583464%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MESSAGE_NO_FULLTXT_LCL-getMessageNoFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,4-EBSCOHOST_CINAHL_WITH_FULL_TEXT-getTOC-object,5-EBSCOHOST_CINAHL_WITH_FULL_TEXT_UL_2024_04_LCL-getTOC-object,6-ISI_WEB_OF_SCIENCE-getAuthor-object,7-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,8-REFWORKS_EXPORT_TOOL-getReference-object,9-NCBI_PUBMED_FREE-getCitedRecord-object,10-SHERPA_RoMEO_LCL-getWebService-object,11-GOOGLE_SCHOLAR_FREE-getWebSearch-object,12-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=0.872289&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15082072-s4F84ED8A-5A1D-11EF-B837-C0B384CE164B" timestamp="2024-08-14T11:12:20Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925517559</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension.</jnl:atitle>
<jnl:jtitle>Journal of Rheumatology</jnl:jtitle>
<jnl:date>2006-05-00</jnl:date>
<jnl:spage>985</jnl:spage>
<jnl:epage>995</jnl:epage>
<jnl:coden>JRHUA9</jnl:coden>
<jnl:issn>0315-162X</jnl:issn>
<jnl:volume>33</jnl:volume>
<jnl:issue>5</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1499-2752</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>JRHUA9</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:f90f5f1b134d6c6ccdb63e856cbd3a66b8f1b123</ctx:identifier>
<ctx:identifier>urn:UUID:s4F84ED8A-5A1D-11EF-B837-C0B384CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)